Outcomes of holmium laser enucleation of the prostate in men with a history of prostatitis: a retrospective study
Prostatitis patients undergoing HoLEP had comparable safety and efficacy profiles to those who did not have prostatitis. On follow-up, 100% of patients with prostatitis did not experience recurrent prostatitis, suggesting that HoLEP may have a role in the management of prostatitis in the presence of benign prostatic enlargement.
Authors
- Devyn Taylor Coskey (ORCID: https://orcid.org/0000-0003-1663-2398)
- Nabila Khondakar (ORCID: https://orcid.org/0000-0003-1269-7274)
- Amy E. Krambeck (ORCID: https://orcid.org/0000-0001-8255-598X)
- Perry Xu (ORCID: https://orcid.org/0000-0002-9441-4380)
- Alyssa McDonald
- Nicholas Dean (ORCID: https://orcid.org/0000-0002-2202-3532)
- Meera Ganesh (ORCID: https://orcid.org/0000-0002-3983-215X)
- Jamie Michael (ORCID: https://orcid.org/0000-0002-6214-1568)
- Kyle Tsai (ORCID: https://orcid.org/0000-0001-6424-052X)
- Allaa Fadl‐Alla
Institutions
- Northwestern University (US)
- University of Alberta (CA)
Publication Details
- Journal
- Therapeutic Advances in Urology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17562872251338430
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00